[1]
“Urticaria in COVID-19 Patient Treated with Lopinavir / Ritonavir : A Case Report”, J Pak Assoc Dermatol, vol. 31, no. 4, pp. 725–730, Mar. 2022, doi: 10.66344/jpad.31.4.2021.1773.